{"product_id":"elekta-five-forces-analysis","title":"Elekta Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Preview—Access the Full Strategic Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eElekta faces moderate supplier power, high buyer scrutiny, regulatory-driven barriers to entry, intense rivalry among oncology-tech players, and evolving substitute threats from emerging therapies; this snapshot highlights key pressure points shaping margins and innovation. The full Porter's Five Forces Analysis unpacks force-by-force ratings, data and strategic implications. Unlock the complete report to inform investment or strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized component suppliers concentration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eLinear accelerator tubes, beam-shaping devices, high-precision bearings and rare-earth magnets come from a small set of qualified vendors, giving suppliers clear leverage on price and lead times. Dual-sourcing is constrained by lengthy qualification and regulatory validation, raising switching costs and inventory needs. Major rare-earth magnet capacity is concentrated in China, increasing geopolitical supply risk. Any supplier disruption can postpone Elekta system deliveries and service SLAs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRadioisotope and dosimetry dependencies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eBrachytherapy sources (Ir-192 half-life 73.83 days; Co-60 half-life 5.27 years), dosimeters and QA phantoms depend on tightly regulated isotope and measurement suppliers subject to IAEA and national certification, limiting vendor switching. Certification and handling constraints raise switching costs and make price hikes hard to offset without product redesign. Strategic inventory management and long-term contracts are vital to mitigate supply and cost risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced electronics and semiconductor exposure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eElekta relies on high-spec semiconductors, GPUs and FPGAs for control systems and imaging, and cyclical shortages have previously increased lead times and component costs, forcing production delays; substituting parts typically requires engineering changes and regulatory re-approval, making swaps costly and slow. Close supplier collaboration and design-for-availability strategies materially reduce this supplier power and operational risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSoftware stack and cloud infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTreatment planning, oncology information systems and AI modules rely on third-party toolkits and cloud providers; 2024 market shares concentrate with AWS ~31%, Azure ~24% and GCP ~11%, raising licensing and interoperability switching costs. Security and certifications (ISO 27001, HIPAA, GDPR) increase vendor stickiness; negotiation power improves with Elekta scale but is bounded by compliance-driven dependency.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDependency: third-party SDKs, cloud APIs\u003c\/li\u003e\n\u003cli\u003eSwitching cost: licensing + integration\u003c\/li\u003e\n\u003cli\u003eStickiness: security\/compliance certifications\u003c\/li\u003e\n\u003cli\u003eLeverage: scale helps but compliance caps bargaining\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eService parts and field logistics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpservice parts and field logistics: precision spares calibrated subassemblies require strict qa traceability limiting generic substitutes increasing supplier leverage regional logistics partners shape response times freight costs directly affecting service margins. slas with hospitals force elekta to hold buffer stocks maintain inventory pools raising working capital. suppliers of specialized calibration test equipment retain pricing power due technical complexity regulatory certification needs in the global medical device aftermarket exceeded billion underscoring scale influence.\u003e\n\u003cp\u003e\u003c\/p\u003e\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLimited substitutes: strict QA\/traceability raises supplier power\u003c\/li\u003e\n\u003cli\u003eLogistics impact: regional partners determine 24–72h response and costs\u003c\/li\u003e\n\u003cli\u003eSLAs drive inventory: elevated buffer stocks increase OPEX\/working capital\u003c\/li\u003e\n\u003cli\u003eCalibration suppliers: concentrated tech suppliers can exert price pressure\u003c\/li\u003e\n\u003cli\u003eMarket scale 2024: global aftermarket \u0026gt;$100bn\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pservice\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupply risk: China \u003cstrong\u003e~80%\u003c\/strong\u003e rare-earths; cloud \u003cstrong\u003e31%\/24%\/11%\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold significant leverage across linac components, rare-earth magnets (China ~80% processing share 2024) and calibrated spares, raising prices and lead times. Dual-sourcing is limited by regulatory requalification and isotope handling (Ir-192 half-life 73.83 days), increasing switching costs and inventory. Cloud\/toolkit concentration (AWS ~31%, Azure ~24%, GCP ~11% 2024) and semiconductors add stickiness and cost risk.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCategory\u003c\/th\u003e\n\u003cth\u003eConcentration\u003c\/th\u003e\n\u003cth\u003e2024 Impact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRare-earths\u003c\/td\u003e\n\u003ctd\u003eChina ~80%\u003c\/td\u003e\n\u003ctd\u003eHigh geopolitical supply risk\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCloud\u003c\/td\u003e\n\u003ctd\u003eAWS 31%\/Azure 24%\/GCP 11%\u003c\/td\u003e\n\u003ctd\u003eLicensing\/switch costs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAftermarket\u003c\/td\u003e\n\u003ctd\u003eFragmented but large\u003c\/td\u003e\n\u003ctd\u003eMarket \u0026gt;$100bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCombines analysis of competitive rivalry, buyer and supplier power, substitution and entry threats to assess Elekta's strategic position in radiotherapy and oncology equipment markets, highlighting disruptive technologies, pricing pressures, and barriers that shape its profitability and growth prospects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA clear, one-sheet Porter's Five Forces analysis for Elekta—perfect for quick strategic decisions; customize pressure levels and swap in current data to assess supplier, buyer, rivalry, substitutes, and new entrant threats.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsolidated hospital systems and GPOs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eConsolidated IDNs and GPOs, which serve over 90% of US hospitals, push Elekta for aggressive pricing and contract terms, intensifying margin pressure.\u003c\/p\u003e\n\u003cp\u003eMulti-year tenders and blanket agreements create repeated competitive auctions, often driving supplier discounts in the 10–25% range.\u003c\/p\u003e\n\u003cp\u003eBuyers routinely demand bundled service and software concessions, and fleet refresh cycles every 7–10 years create clear switching windows.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic tenders and reimbursement constraints\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eNational health systems award many radiotherapy contracts via price-centric tenders, where price often counts for 30–70% of scoring; reimbursement caps in 2024 continue to constrain achievable ASPs, depressing device prices by mid-single digits annually in several EU markets. Lengthy budget cycles extend negotiations and favor lowest total cost of ownership, while proven cost-effectiveness (QALY gains, lower retreatment rates) materially influences award decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh switching costs but evaluative power\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInstalled-base integration with workflows, QA and training creates strong inertia—Elekta’s global installed base exceeds 5,000 systems, driving high switching costs—yet buyers use cross-vendor pilots and head-to-head trials to extract concessions. Contracts now hinge on uptime (industry target ~98–99%), dose-accuracy tolerances (~±2%) and adaptive-RT capabilities (adoption ~10% in 2024), and performance-based clauses appear in over 30% of recent procurements.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDemand for comprehensive solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIn 2024 customers increasingly demand end-to-end ecosystems covering hardware, treatment planning and oncology IT, using that leverage to seek package discounts and unified SLAs; interoperability with existing systems is frequently a condition of sale, and demonstrated outcomes data plus usability carry high decision weight.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eEnd-to-end ecosystems drive bundled pricing and SLA demands\u003c\/li\u003e\n\u003cli\u003eInteroperability often a formal sales requirement\u003c\/li\u003e\n\u003cli\u003eOutcomes evidence and usability are primary purchase criteria\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAftermarket service leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAftermarket service leverage is central for Elekta because service contracts and upgrades drive recurring revenue and lifetime value, and Elekta's 2024 reports emphasize services as a strategic recurring segment. Buyers use competitive service bids to push down fees, making uptime guarantees (commonly 99% SLAs) and remote diagnostics table stakes. Transparent TCO and predictable lifecycle costs are decisive for renewal and upgrade timing.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eService-driven recurring revenue: highlighted in Elekta 2024 disclosures\u003c\/li\u003e\n\u003cli\u003eCompetitive bids compress margins, buyers seek 99%+ uptime\u003c\/li\u003e\n\u003cli\u003eRemote diagnostics standard; TCO transparency influences renewals\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIDN\/GPO leverage: \u003cstrong\u003e\u0026gt;90%\u003c\/strong\u003e coverage, \u003cstrong\u003e10–25%\u003c\/strong\u003e discounts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eConsolidated IDNs\/GPOs (covering \u0026gt;90% of US hospitals) and price-focused tenders (price weight 30–70%) give customers strong leverage, pushing discounts often 10–25% and compressing ASPs. Multi-year contracts, bundled service\/software demands and 5,000+ installed base create switching windows but high inertia; uptime SLAs (~99%) and adaptive-RT adoption (~10% in 2024) shape negotiations.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024 value\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eIDN\/GPO coverage\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90% US hospitals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTypical supplier discounts\u003c\/td\u003e\n\u003ctd\u003e10–25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrice weight in tenders\u003c\/td\u003e\n\u003ctd\u003e30–70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInstalled base\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;5,000 systems\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUptime SLAs\u003c\/td\u003e\n\u003ctd\u003e~99%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdaptive-RT adoption\u003c\/td\u003e\n\u003ctd\u003e~10%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eElekta Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Elekta Porter’s Five Forces analysis you'll receive after purchase—fully formatted and ready for use. It covers supplier power, buyer power, threat of entrants, threat of substitutes, and competitive rivalry specific to Elekta. No placeholders or samples—instant download upon payment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56163250831737,"sku":"elekta-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/elekta-five-forces-analysis.png?v=1762716428","url":"https:\/\/portersfiveforce.com\/products\/elekta-five-forces-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}